Skip to main content

Table 2 Univariate analysis for preoperative prognostic factors in cause-specific survival of patients with invasive pancreatic neoplasms after repeat pancreatectomy

From: Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Clinico-pathological parameters

Univariate analysis

n = 28

HR (95% CI)

p value

Age (years: ≥ 68/≤ 67)

13 / 15

0.89 (0.29–2.68)

0.83

Sex (M/F)

17 / 11

1.64 (0.52–6.26)

0.41

Diagnosis at initial operation (PC/IPMN)

22 / 6

4.05 (0.80–73.73)

0.10

DPM at initial operation (+/−)

4 / 24

0.49 (0.03–2.66)

0.52

Recurrence at the margin of initial resection (+/−)

5 / 23

0.27 (0.02–1.43)

0.14

Chemo (radio) Tx after initial diagnosis of recurrence (+/−)

9 / 19

2.76 (0.88–8.35)

0.08

Preoperative CA19–9 (≥ 100/<  100) (U/mL)

14 / 14

0.77 (0.25–2.43)

0.64

NLR (≥ 3.0/<  3.0)

14 / 14

1.36 (0.45–4.51)

0.59

LMR (≥ 3.3/<  3.3)

20 / 8

0.25 (0.08–0.81)

0.022*

Intervals from 1st to 2nd operation (≥ 24 m/<  24 m)

20 / 8

0.78 (0.25–2.90)

0.69

  1. n the number of participants, HR hazard ratio, CI confidence interval, PC pancreatic cancer, IPMN intra-papillary mucinous neoplasm. *: significant value. DPM dissected peripancreatic tissue margin, Tx therapy, NLR neutrophil to lymphocyte ratio, LMR lymphocyte to monocyte ratio